Last $7.87 USD
Change Today +0.06 / 0.77%
Volume 6.6K
IRIX On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GM
As of 8:10 PM 09/17/14 All times are local (Market data is delayed by at least 15 minutes).

iridex corp (IRIX) Snapshot

Open
$8.00
Previous Close
$7.81
Day High
$8.00
Day Low
$7.80
52 Week High
01/22/14 - $11.00
52 Week Low
09/26/13 - $5.77
Market Cap
77.7M
Average Volume 10 Days
12.3K
EPS TTM
$0.17
Shares Outstanding
9.9M
EX-Date
--
P/E TM
46.3x
Dividend
--
Dividend Yield
--
Current Stock Chart for IRIDEX CORP (IRIX)

Related News

No related news articles were found.

iridex corp (IRIX) Related Businessweek News

No Related Businessweek News Found

iridex corp (IRIX) Details

IRIDEX Corporation develops, manufactures, markets, sells, and services medical laser systems and associated instrumentation for the treatment of the sight-threatening eye diseases worldwide. Its ophthalmology products consist of laser consoles, such as visible (yellow) photocoagulator console, infrared photocoagulator consoles, micropulse enabled consoles, and multi-wavelength laser system configurations. The company also provides ophthalmic delivery devices and other products, such as TxCell scanning laser delivery systems; TruFocus laser indirect ophthalmoscopes; slit lamp adapters; and operating microscope adapters. In addition, it offers EndoProbe, a fiber optic delivery device used for endophotocoagulation, a retinal treatment procedure; G-Probe, a sterile consumable multi-use product used in procedures to treat medically and surgically uncontrolled glaucoma; and DioPexy Probe, a hand-held instrument used in procedures to treat retinal tears. Further, the company provides GreenTip Soft Tip Cannula, a sterile disposable product, which allows surgeons to visualize and access the proximity of the retina while performing a fluid air exchange during a vitrectomy procedure; and MoistAir in-line air humidifier that provides humidified air to the eye during fluid air exchange. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, and office clinics. It sells and markets its products through a direct sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was founded in 1989 and is headquartered in Mountain View, California.

101 Employees
Last Reported Date: 03/27/14
Founded in 1989

iridex corp (IRIX) Top Compensated Officers

Chairman of the Board, Interim Chief Executiv...
Total Annual Compensation: $200.0K
Chief Financial Officer, Chief Operating Offi...
Total Annual Compensation: $284.7K
Vice President of Operations
Total Annual Compensation: $138.5K
Compensation as of Fiscal Year 2013.

iridex corp (IRIX) Key Developments

IRIDEX Corporation Presents at Wedbush 2014 Life Sciences Management Access Conference, Aug-12-2014 01:55 PM

IRIDEX Corporation Presents at Wedbush 2014 Life Sciences Management Access Conference, Aug-12-2014 01:55 PM. Venue: Le Parker Meridien, New York, New York, United States. Speakers: William M. Moore, Chairman of the Board, Interim Chief Executive Officer and Interim President.

Garrett A. Garrettson Resigns from the Board of Directors of Iridex Corporation

On July 29, 2014, Dr. Garrett A. Garrettson resigned from the Board of Directors of IRIDEX Corporation and all committees thereof, effective July 29, 2014.

IRIDEX Corporation Announces Consolidated Unaudited Earnings Results for Second Quarter and Six Months Ended June 28, 2014; Provides Earnings Guidance for Third Quarter of 2014

IRIDEX Corporation announced consolidated unaudited earnings results for second quarter and six months ended June 28, 2014. For the quarter, the company reported total revenues of $10,589,000, income from operations of $400,000, income from operations before provision for income taxes of $309,000, net income of $297,000 or $0.03 basic and diluted per share compared to the total revenues of $9,210,000, income from operations of $515,000, income from operations before provision for income taxes of $418,000, net income of $415,000 or $0.04 diluted per share for the same quarter a year ago. For the six months, the company reported total revenues of $20,918,000, income from operations of $997,000, income from operations before provision for income taxes of $809,000, net income of $784,000 or $0.07 diluted per share compared to the total revenues of $18,149,000, income from operations of $1,412,000, income from operations before provision for income taxes of $1,297,000, net income of $1,289,000 or $0.13 diluted per share for the same quarter a year ago. The company provided earnings guidance for third quarter of 2014. The company expects to achieve revenue of $10.0 million to $10.3 million, representing growth of 5% to 8% over last year's third quarter. Gross margin is anticipated to come in between 48% and 50%, and operating expenses are expected to be $4.6 million to $4.8 million.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IRIX:US $7.87 USD +0.06

IRIX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cutera Inc $10.04 USD -0.14
Ellex Medical Lasers Ltd A$0.34 AUD +0.015
Lutronic Corp 19,600 KRW -100.00
STAAR Surgical Co $11.62 USD +0.37
Synergetics USA Inc $3.25 USD 0.00
View Industry Companies
 

Industry Analysis

IRIX

Industry Average

Valuation IRIX Industry Range
Price/Earnings 47.0x
Price/Sales 1.9x
Price/Book 3.0x
Price/Cash Flow 44.7x
TEV/Sales 1.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IRIDEX CORP, please visit www.iridex.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.